Researchclopedia
Research
Researchers
Institutions
Topics
Submit
About
Search...
⌘
K
Command Palette
Search for a command to run...
Back to research
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma
2019
133 citations
Journal Article
gold Open Access
Field-Weighted Citation Impact:
12.21
Efficacy and tolerability of anti-programmed death-ligand 1 (PD-L1) antibody (Avelumab) treatment in advanced thymoma | Researchclopedia
·
National Institutes of Health
Arlene Berman
·
National Institutes of Health
Éva Szabó
·
National Institutes of Health
Ravi A. Madan
·
National Institutes of Health
Leomar Y. Ballester
·
National Institutes of Health
Stefania Pittaluga
·
National Institutes of Health
Renee N. Donahue
·
National Institutes of Health
Yo-Ting Tsai
·
National Institutes of Health
Lauren M. Lepone
·
National Institutes of Health
Kevin M. Chin
·
Merck (Germany)
Fiona Ginty
·
GE Global Research (United States)
Anup Sood
·
GE Global Research (United States)
Stephen M. Hewitt
·
National Institutes of Health
Jeffrey Schlom
·
National Institutes of Health
Raffit Hassan
·
National Institutes of Health
James L. Gulley
·
National Institutes of Health